RARE · Transaction Mar 3, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · RARE
+0.81% · +$0.1200 · Vol Not reported
Pre-market · updated 04:05:35 ET
Ultragenyx Pharmaceutical Inc
Biotechnology
$15.00
Follow $RARE
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $RARE by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredThu Sep 24 · pre-market · Pre-market · regular session opens 9:30 ET · RARE
MethodologyAnalyst data unavailable at compute time
RARE
Ultragenyx Pharmaceutical Inc
Thu Sep 24 · pre-market · Pre-market · regular session opens 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
49/ 100
Veridion Score
Middle range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Thu Sep 24 · pre-market · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is RARE moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Ultragenyx Pharmaceutical Inc
PHARMACEUTICAL PREPARATIONSListed since
2014
Employees
1K
Country
US
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$14.88
Last session
Day high
$14.88
Last session
Day low
$14.88
Last session
Previous close
$14.88
52W high
$36.54
-58.95% from high
52W low
$12.88
9% of range
Market cap
$1.5B
EPS
$-5.7200
Beta
0.42
Shares out
98.6M
Avg volume
5.1M
VWAP
$14.88
Last session
Price history computed in-house
1W
+3.45%
1M
-43.31%
3M
-51.25%
1Y
-47.84%
YTD
-34.78%
SMA 50 $23.17 · below
SMA 200 $24.83 · below
52W position 9%
RARE overview
Related filings and maps
Public disclosures
Congress activity in RARE
Official filing ↗
Ultragenyx Pharmaceutical Inc. - Common Stock · Transaction Mar 3, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
RARE · Transaction Feb 18, 2026 · Filed Mar 9, 2026 · $1,001 to $15,000
Ultragenyx Pharmaceutical Inc. - Common Stock · Transaction Feb 18, 2026 · Filed Mar 9, 2026 · $1,001 to $15,000
Ultragenyx Pharmaceutical Inc. - Common Stock · Transaction Aug 8, 2025 · Filed Sep 12, 2025 · $1,001 to $15,000
Federal contracts
RARE contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RARE in this window.
Lobbying spend
RARE lobbying filings, year to date.
Registered lobbying filings matched to Ultragenyx Pharmaceutical Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RARE in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for RARE.
Options
Sovereign unlock shows live options positioning for RARE.